Lena Biosciences

company

About

Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapy testing.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$150K
Industries
Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapies, biomedical research and drug testing. Its new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enables customers to emulate multiple organs, deliver and test drugs in a standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$150K
Lena Biosciences has raised a total of $150K in funding over 2 rounds. Their latest funding was raised on Jan 1, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2016 Grant $150K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Lena Biosciences is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant